Activity continues to buzz in the private equity world. For example, according to the Wall Street Journal (subscription required), it appears that IMS (NYSE: RX) is in advanced talks to take the company private. As a result, the shares of the company soared 22% in Monday's trading.

No doubt, a deal could fall apart. But, the fact remains that IMS has definitely attracted interest. Some of the suitors include: TPG, Silver Lake, and BC Partners. The deal could be worth as much as $3.5 billion.

IMS got its start in the mid 1950s when the founders -- Bill Frohlich (an advertising executive) and David Dubow -- saw an opportunity to build a unique information company for the pharma industry. The timing was perfect as the company quickly grew.

Continue reading IMS is buyout bait?

IMS is buyout bait? originally appeared on BloggingStocks on Tue, 20 Oct 2009 14:40:00 EST. Please see our terms for use of feeds.

This post is part of a 12-article feature that can be read here: Today's best income ideas.

"You don't have to be in the upper tax bracket to rake in higher returns from these tax-free bonds," says income expert Carla Pasternak.

In her High Yield Investing, she looks two favorite vehicles: Morgan Stanley Insured Municipal Securities (NYSE: IMS), with a tax-equivalent yield of 7.9% and Western Asset Municipal High Income Fund (NYSE: MHF), with a tax-equivalent yield of 11.1%.

Continue reading High returns from tax-free muni bond funds

High returns from tax-free muni bond funds originally appeared on BloggingStocks on Sun, 01 Mar 2009 15:30:00 EST. Please see our terms for use of feeds.